Denali Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Denali Therapeutics Inc
TickerDNLI
CIK #0001714899
CUSIP24823R105
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address151 Oyster Point Blvd 2Nd Floor, South San Francisco, CA 94080
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Denali Therapeutics Inc 2024-03-01 499.7 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001714899] 10-K
[0001714899] 10-Q
[0001714899] 3
[0001714899] 4
[0001714899] 5
[0001714899] 8-K
[0001714899] D
[0001714899] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
T Rowe Price Investment Management Inc Denali Therapeutics Inc [2026-05-15] 0.0
Capital Research Global Investors Denali Therapeutics Inc [2024-11-12] 5.5
FMR LLC Denali Therapeutics Inc [2024-08-16] 0.0
Wellington Management Group LLP Denali Therapeutics Inc [2024-02-08] 5.26
Temasek Holdings Private Ltd Denali Therapeutics Inc [2023-03-30] 5.0
Price T Rowe Associates Inc /MD/ Denali Therapeutics Inc [2021-02-16] 5.3
BlackRock Inc Denali Therapeutics Inc [2021-02-02] 5.3
Biogen Inc Denali Therapeutics Inc [2020-09-28] 11.16
BlackRock Inc Denali Therapeutics Inc [2020-02-07] 5.5
Vanguard Group Inc Denali Therapeutics Inc [2019-02-11] 6.9
Flagship Ventures Fund V LP Denali Therapeutics Inc [2018-02-14] 10.1
Bratton Douglas K Denali Therapeutics Inc [2018-02-13] 22.8
Arch Venture Fund VIII LP Denali Therapeutics Inc [2018-02-02] 12.3
Baillie Gifford & Co Denali Therapeutics Inc [2018-01-31] 5.59
FMR LLC Denali Therapeutics Inc [2017-12-15] 0.0
Form 3/4/5 Filer 2011 - 2026
Baker Brothers Life Sciences LP
Baker Bros Advisors GP LLC
667 LP
Baker Julian
Baker Felix
Denali Therapeutics Inc
Baker Bros Advisors LP
Flatley Jay T
Krognes Steve E
Cook Jennifer E
Thornberry Nancy
Schenkein David P
Klein Peter S
van Hauwermeiren Timothy
Chin Peter Scott
Schuth Alexander O
Watts Ryan J
Ho Carole
Tessier-Lavigne Marc
Sato Vicki L
Harris Erik
Cole Douglas G
Nelsen Robert
Crestline Management LP
Bratton Douglas K
Crestline Investors Inc
Crestline SI GP LP
AKDL LP
Bratton Capital Inc
Bratton Capital Management LP
Neuro Line Partners LP
Biogen MA Inc
Biogen Inc
Arch Venture Partners VIII LP
Bybee Clinton
Arch Venture Partners VIII LLC
Arch Venture Fund VIII LP
Crandell Keith
FMR LLC
FIL Ltd
Flagship Ventures Fund V LP
Afeyan Noubar
Flagship Ventures Fund V General Partner LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Watts Ryan J
Common Stock
2026-01-06 Sell 35,198 $16.50 580,767
Schuth Alexander O
Common Stock
2026-01-06 Sell 17,218 $16.50 284,097
Schuth Alexander O
Stock Option (right to buy) · derivative
2026-01-03 Grant 173,100 $0.00
Watts Ryan J
Common Stock
2026-01-03 Grant 78,960 $0.00
Schuth Alexander O
Common Stock
2026-01-03 Grant 57,700 $0.00
Watts Ryan J
Stock Option (right to buy) · derivative
2026-01-03 Grant 236,880 $0.00
Baker Brothers Life Sciences LP +5
$0.01 Prefunded Warrants · derivative
2025-12-11 Buy 190,523 $17.49 3,332,247
Baker Brothers Life Sciences LP +5
$0.01 Prefunded Warrants · derivative
2025-12-11 Buy 2,095,191 $17.49 36,644,891
van Hauwermeiren Timothy
Stock Option (right to buy) · derivative
2025-11-04 Grant 31,897 $0.00
van Hauwermeiren Timothy
Common Stock
2025-11-04 Grant 10,632 $0.00
Common Stock
2025-09-03 Gift 50,000 $0.00
Ho Carole
Common Stock
2025-08-13 Sell 806 $14.64 11,800
Schuth Alexander O
Common Stock
2025-08-12 Sell 2,937 $13.58 39,884
Ho Carole
Common Stock
2025-08-12 Sell 2,937 $13.58 39,884
Ho Carole
Common Stock
2025-08-05 Option exercise 44,655 $0.68 30,365
Ho Carole
Stock Option (right to buy) · derivative
2025-08-05 Option exercise 44,655 $0.00
Watts Ryan J
Stock Option (right to buy) · derivative
2025-07-09 Option exercise 40,000 $0.00
Watts Ryan J
Common Stock
2025-07-09 Sell 495,282 $15.00 7,429,230
Watts Ryan J
Common Stock
2025-07-09 Option exercise 40,000 $5.28 211,200
Watts Ryan J
Common Stock
2025-07-09 Option exercise 455,282 $0.68 309,592
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 271 137,904,271
2025-12-31 251 140,032,127
2025-09-30 241 125,812,726
2025-06-30 231 128,244,966
2025-03-31 225 131,744,851
2024-12-31 226 125,025,487
2024-09-30 219 124,055,198
2024-06-30 207 122,306,731
2024-03-31 214 122,578,724
2023-12-31 211 113,703,705
2023-09-30 196 105,398,260
2023-06-30 205 103,852,442
Form 13F Holdings
Firm Period DFND Voting Shares
E Ohman J or Asset Management AB [2026-06-30] SOLE 160,000 160,000
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 704 16,467
Breakwater Capital Group [2026-06-30] SOLE 0 15,601
Contravisory Investment Management Inc [2026-06-30] SOLE 14,674 14,674
B Riley Wealth Advisors Inc [2026-06-30] SOLE 12,813 12,813
PSP Research LLC [2026-06-30] SOLE 0 8,463
Versant Capital Management Inc [2026-06-30] SOLE 1,633 1,633
Gamma Investing LLC [2026-06-30] DFND 1,549 1,549
Farther Finance Advisors LLC [2026-06-30] SOLE 0 537
IFP Advisors LLC [2026-06-30] SOLE 503 503
Owl Creek Wealth Partners LLC [2026-06-30] SOLE 0 450
City State Bank [2026-06-30] SOLE 250 250
HM Payson & Co [2026-06-30] SOLE 200 200
MassMutual Private Wealth & Trust FSB [2026-06-30] SOLE 143 143
True Wealth Design LLC [2026-06-30] SOLE 0 88
Physician Wealth Advisors Inc [2026-06-30] SOLE 0 76
Fortitude Family Office LLC [2026-06-30] SOLE 61 61
Handelsbanken Fonder AB [2026-06-30] SOLE 0 59
JFS Wealth Advisors LLC [2026-06-30] SOLE 0 51
Bear Mountain Capital Inc [2026-06-30] SOLE 21 22
Dinuzzo Private Wealth Inc [2026-06-30] SOLE 0 10
LRI Investments LLC [2026-06-30] SOLE 3 3
Maryland Capital Advisors Inc [2026-06-30] DFND 1 1
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com